News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Patent News
Kymab Succeeds In Revoking Regeneron Pharmaceuticals, Inc. (REGN)’s European Patent 9/19/2014
Salix Pharmaceuticals, Ltd. (SLXP) Secures Additional Intellectual Property Relating To Rifaximin 9/18/2014
Biostar Pharmaceuticals, Inc. (BSPM) Files A PRC Patent Application For Oleanolic Acid Injection, Its New Drug Product For Hepatitis B And Liver Cancer 9/18/2014
Biocept, Inc. (BIOC) Granted Patent In China For Its Microfluidic Channel Technology Used To Capture Circulating Tumor Cells 9/18/2014
Patent Position Of Merus' MeMo® Mouse Strengthened by Ruling of European Patent Office 9/18/2014
Regen BioPharma Files Patent Application On New Therapy That Uses the "Innate" Immune System To Kill Cancer 9/17/2014
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Issue Of A New Patent For Beleodaq™ (Belinostat) For Injection With Patent Term Adjustment Till 2027 9/16/2014
Trevena, Inc. (TRVN) Granted Key U.S. Composition Of Matter Patent For TRV130 9/16/2014
Advanced Medical Isotopes Corporation Licensed Brachytherapy Seed Patent Granted 9/16/2014
Oculus Innovative Sciences, Inc. (OCLS) Strengthens Intellectual Property Portfolio With Allowance Of Four New Patents For Microcyn® Technology 9/16/2014
Galectin Therapeutics Announces Issuance Of U.S. Patent For GR-MD-02 In Diabetic Nephropathy 9/15/2014
Dyax Corp. (DYAX) Announces Issuance Of Two Key U.S. Patents For DX-2930 9/15/2014
Marina Biotech, Inc. (MRNA) Announces The Continued Worldwide Expansion Of Its Delivery Technology Intellectual Property Estate 9/15/2014
NeoStem, Inc. Announces Licensing Of Patent Portfolio From The Rockefeller University Expanding Its Cancer Immunotherapy Intellectual Property Portfolio 9/11/2014
Marrone Bio Innovations Receives Patent For Use Of Chromobacterium To Control Corn Rootworm Larvae Infestation 9/11/2014
Lakewood-Amedex Inc. Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 9/11/2014
Egalet Announces Issuance Of U.S. Patents Covering Guardian™ Technology And Product Candidates 9/11/2014
Gentag, Inc.'s Disposable NFC Biomarker Patent Receives Notice Of Allowance From The European Patent Office 9/9/2014
GenSpera Receives Patent On Prodrug Targeted For Prostate Cancer 9/9/2014
Mersana Therapeutics, Inc. Strengthens Antibody-Drug Conjugate Intellectual Property Position With Issuance Of Three Additional U.S. Patents 9/9/2014
Flexion Therapeutics (FLXN) Announces Issuance Of U.S. Composition Of Matter Patent For Lead Candidate FX006 9/9/2014
BerGenBio AS Granted Platform Patent - Cellselect™ Platform Also Described In Peer-Reviewed Journal 9/8/2014
Argos Therapeutics, Inc. (ARGS) Announces Issuance Of Arcelis® Technology Platform Patent 9/8/2014
Advanced Cell Technology Announces Issuance Of Patent Covering Dendritic Cells Manufacturing From Renewable Stem Cell Sources 9/5/2014
Can-Fite BioPharma (CFBI) Issued Japanese Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/5/2014
Alitair Pharmaceuticals Receives A U.S. Composition Of Matter Patent For Benzonatate Polacrilex 9/5/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance of Fourth US Patent Protecting Oxtellar XR® 9/4/2014
KineMed, Inc. Receives U.S. Patent Allowance For Noscapine To Treat ALS, Parkinson’s Disease, And Diabetic Neuropathy 9/4/2014
Clearside Biomedical Announces Fourth Patent Allowance In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 9/4/2014
Rexahn Pharmaceuticals, Inc. (RNN) Receives A Notice Of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted Cancer Drug Delivery Platform 9/3/2014
Suven Life Sciences Ltd Secures (3) Product Patents For Their NCEs In South Korea, China And Canada 9/3/2014
Orexigen Therapeutics, Inc. (OREX) Expands NB32 Intellectual Property Portfolio With New U.S. Patent 9/3/2014
DelMar Pharmaceuticals Receives Notice Of Allowance For Second U.S. Patent For VAL-083 9/3/2014
United States Patent & Trademark Office Issues Three New Standard Essential Patents To Spherix (SPEX) 9/2/2014
Cellular Dynamics International Awarded U.S. Patent Covering Automated Production Of All Human Pluripotent Stem Cells 8/29/2014
United Therapeutics Corporation (UTHR) Release: District Court Decision Received In Remodulin Patent Case 8/29/2014
iBio, Inc. (IBIO) Receives European Patent Allowances For Protein Expression Technology 8/28/2014
Onxeo Strengthens Beleodaq® Patent Protection In The U.S. Until 2027 8/28/2014
TxCell Granted Five New Patents In Major Global Territories For Core Technology And Astria Platform Since January 2014 8/27/2014
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 8/27/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Rnai-Mediating, Double-Stranded Molecules Of 19 To 52 Nucleotides In Length 8/27/2014
Ryogen LLC Awarded Two U.S. Patents Directed To Hepatitis C And Diabetes 8/27/2014
Actavis (ACT) Confirms Generic Neupro® Patent Challenge 8/25/2014
MultiCell Technologies Inc. (MCET.OB) Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer 8/25/2014
Dicerna Pharmaceuticals (DRNA) Announces The Issuance Of Multiple Patents Covering Claims For Dicer Substrate SiRNAs 8/21/2014
BioLineRx Ltd. Receives Notice Of Allowance For U.S. Patent On BL-7010 Covering Use Of Novel Polymer In Prevention Of Gluten Toxicity 8/21/2014
Achillion Pharmaceuticals, Inc. (ACHN) Granted U.S. Patent For ACH-3102 And Structurally Related NS5A Inhibitors 8/20/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Rnai-Mediating Double-Stranded Molecules Comprising Up To 25 Base Pairs 8/20/2014
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent in Spain For Oral Administration Of Insulin 8/19/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Further Expanding Stem Cell Technology Platform 8/19/2014
BioBlast Pharma (ORPN) Receives Notice Of Allowance From USPTO For Its Novel Fusion Protein-Based Platform For The Treatment Of Friedrich's Ataxia 8/18/2014
Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent For Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform 8/14/2014
Access Pharmaceuticals (ACCP) Awarded Japan Patent For MuGard And ProctiGard 8/14/2014
La Jolla Pharmaceutical Company (LJPC) Receives Notice Of Allowance For Additional Patent Claims Covering Modified Pectin For The Treatment Of Chronic Inflammation 8/14/2014
Trevi Therapeutics Announces The Issuance Of Two Patents Covering The Oral Sustained Release Formulation Of Nalbuphine ER 8/14/2014
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Nonalcoholic Fatty Liver Disease 8/12/2014
eAgile Awarded Patent For RFID Intelligent Packaging Breakthrough 8/12/2014
EnGeneIC Pty Ltd Receives Patent From The USPTO For EDV™ Nanocell Technology 8/11/2014
InVivo Therapeutics Corporation (NVIV) Receives Notice Of Allowance On Patent Covering Neuro-Spinal Scaffold And Neuro-Spinal Scaffold Plus Stem Cells 8/11/2014
Extending Patent Protections To Discover The Next Life-Saving Drugs 8/11/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their Nces In Australia And Eurasia 8/6/2014
Islet Sciences Receives Notice Of Allowance For U.S. Patent Covering Novel IL-12 Inhibitors 8/6/2014
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of Additional Notices Of Allowance With Claims Covering VIMOVO®(Naproxen / Esomeprazole) Delayed Release Tablets 8/6/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 8/6/2014
Menlo Park's TesoRx Locks In $10 Million, Secures Key Patent And Taps Renowned Urologist As Chief Medical Officer 8/5/2014
Galectin Therapeutics Receives U.S. Patent For GR-MD-02 Composition Of Matter 8/5/2014
Trevena, Inc. (TRVN) Granted Key U.S. Method Of Use Patent For TRV027 8/5/2014
United States Patent Issued To Adamas Pharmaceuticals (ADMS) 8/5/2014
CDEX Inc. (CDEX) Granted Notice Of Allowance For U.S. Patent Application Covering Identification And Determination Of Chemical Substances Using Enhanced Photoemission Spectroscopy 7/31/2014
Mystic Pharmaceuticals Receives Notice Of Allowance For Novel Powder Drug Delivery Technology 7/31/2014
Transgenomic, Inc. (TBIO) Announces Issuance Of New European Patent Covering COLD-PCR Technologies 7/31/2014
GenSpera Announces US Patent For Methods And Compositions For The Detection, Imaging And Treatment Of Cancer 7/30/2014
Ryogen LLC Awarded Two Patents Directed To Polynucleotide Sequences That Play Key Roles In Various Cancers 7/29/2014
Advaxis, Inc. Receives Notice Of Allowance For Cancer Immunotherapies Patent In Japan 7/28/2014
VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds For Prevention Of Mosquito-Borne Illnesses 7/28/2014
MYOS (MYOS) Receives Notice Of Allowance Of U.S. Patent Application For Proprietary Manufacturing Methods Of Fortetropin 7/24/2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE 7/22/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Conjugate-Based Delivery Of RNA Therapeutics 7/22/2014
U.S. Patent Office Grants McCord Research Endothelial Cell Treatment Patent 7/22/2014
Particle Sciences And Eyeon Therapeutics Receive Patent On Novel Dry Eye Technology 7/22/2014
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers 7/21/2014
Agile Therapeutics, Inc. Announces Allowance Of Additional Patent Claims For Skinfusion® 7/18/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Integral Molecular, Inc. Announces Patent Allowance For Dengue Research Technology 7/18/2014
Columbia Laboratories, Inc. (CBRX) Expands Its Intellectual Property Portfolio Following Receipt Of U.S. Patent 7/17/2014
Lipocine Inc. (LPCN) Announces Issuance Of U.S. Patent For LPCN 1021 7/16/2014
InSite Vision (ISV) Announces The Issuance Of Broad U.S. Patent Covering Bromfenac Formulations In Durasite® 7/16/2014
Arena Pharmaceuticals, Inc. (ARNA) Issued Patent For APD371 By United States Patent And Trademark Office 7/16/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
Kraig Biocraft Laboratories, Inc. Announces U.S. Patent And Trademark Office Has Registered The Company's Monster Silk® Trademark 7/15/2014
C4X Discovery Patent Granted In Japan 7/15/2014
BioTime (BTX) Announces Issuance Of 14 Patents In The Fields Of Regenerative Medicine, And Cancer Diagnosis And Therapy 7/14/2014
Transplant Genomics Inc. Announces Exclusive License To Patent Rights Co-Owned By The Scripps Research Institute And Northwestern University 7/14/2014
Zogenix, Inc. (ZGNX) Announces New Patent Valid Through 2032 For DosePro® Needle-Free Delivery System 7/14/2014
Actavis (ACT) Confirms Generic Diclegis® Patent Challenge 7/14/2014
Cellular Dynamics International Awarded Patents Covering Derivation Of Pluripotent Stem Cells From Fresh Or Banked Human Blood Samples 7/10/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014
Rosetta Genomics Ltd. (ROSG) Receives Notice Of Allowance For U.S. Patent For The Treatment Of Ovarian Cancer 7/10/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Palatin Technologies (PTN) Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides 7/9/2014
Alkermes plc (ALKS) Announces Notices of Allowance For U.S. Patents For Four CNS Pipeline Candidates 7/9/2014
ZS Pharma (ZSPH) Announces Allowance Of Two U.S. Patent Applications For ZS-9 7/8/2014
Sirnaomics Strengthens Its IP Position For Advancing The Company's Novel siRNA Therapeutics Programs 7/8/2014
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014
Aegis Therapeutics, LLC Awarded US Patent For Stable "Shirt-Pocket" Insulin Suitable For Metered Nasal Spray Or Injection 7/8/2014
Actavis (ACT) Confirms Generic Ampyra® Patent Challenge 7/8/2014
Seres Health Announces Allowance For Key Patent On The Use Of Synergistic Bacterial Compositions 7/7/2014
Q Therapeutics, Inc. Announces First U.S. Patent Relating To Fifth Patent Family On Neural Cells 7/7/2014
22nd Century Group, Inc. Announces Allowance of U.S. Patent For Regulating Nicotine in Tobacco Using Transcription Factor Gene 7/3/2014
OncoMed Pharmaceuticals, Inc. (OMED) Granted Broad FZD-Fc Composition-Of-Matter And Use Patent In U.S. 7/2/2014
Collegium Pharmaceutical, Inc. Announces Issuance Of U.S. Patent Covering Oxycodone DETERx®, An Abuse-Deterrent, Extended-Release Opioid Product 7/2/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Broad U.S. Patent For Neuvax™ (Nelipepimut-S) 7/1/2014
Valensa Is Granted New Patents For "Worry Free" Chia-Based Ingredients 7/1/2014
Mati Therapeutics Expands Patent Portfolio 6/30/2014
Actavis (ACT) Confirms Generic Zubsolv® Patent Challenge 6/30/2014
Premier Biomedical Announces Important Patent Award For A Potential Multi-Billion Dollar Drug For The Treatment Of Fibromyalgia And Neuralgia 6/30/2014
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014
Opko Health, Inc. Granted Patent from European Patent Office For Lagova™ 6/27/2014
Regulus Therapeutics, Inc. Announces Patent Grant From U.S. Patent Office In Sarnow Patent Estate On Microrna Therapeutics For The Treatment Of HCV 6/25/2014
Shire Pharmaceuticals (SHPG) Release: Vyvanse® Patents Found To Be Infringed And Valid By U.S. District Court 6/25/2014
Ryogen LLC Is Awarded Patent For Polynucleotides Related To Tumor-Suppressing Subtransferable Candidate 4 6/24/2014
BioInvent (BOVNF) Granted U.S. Patent For BI-505 And Apoptosis-Inducing ICAM-1 Antibodies 6/24/2014
Advaxis, Inc. Receives Notice Of Allowance From U.S. Patent Office For Two Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy ADXS-Cher2 6/23/2014
Perrigo Company (PRGO) Announces Settlement In Proair® HFA Patent Case 6/20/2014
Actavis (ACT) Confirms District Court Ruling In Generic Exelon® Patch Patent Suit 6/19/2014
Pluristem Therapeutics (PSTI) Granted Patent In Russia For Treatment Of Inflammatory Bowel Disease Using Placenta-Derived Cells 6/19/2014
TriLink BioTechnologies Awarded Patents For Novel Ligation Technology In US, Europe And New Zealand 6/19/2014
Drawbridge Pharmaceuticals Granted New Anaesthesia Patent For Phaxan™ In China 6/18/2014
Keryx Biopharmaceuticals (KERX) Announces Issuance Of Two U.S. Patents For Zerenex(TM) Covering Orally Administrable Forms Of Ferric Citrate 6/18/2014
ProLynx Issues U.S. Patent Covering Controlled Release Drug Conjugates 6/18/2014
Patrys Limited (PAB.AX) Granted Third U.S. Patent For Lead Clinical Product PAT-SM6 6/18/2014
Forest Laboratories, Inc. (FRX) Obtains Six Months U.S. Pediatric Exclusivity for NAMENDA® and NAMENDA XR® 6/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Reaches Settlements In NUVIGIL® Patent Case 6/17/2014
ArmaGen Technologies, Inc. Receives Notice Of Allowance For U.S. Patent Covering Novel Investigational Therapy For Hunter Syndrome 6/17/2014
Essentialis Announces The Grant Of Its First Japanese Patent Which Provides Extensive Protection To DCCR In The Treatment Of Prader-Willi Syndrome 6/17/2014
Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions 6/16/2014
Arrowhead Research Corporation (ARWR) Issues A Statement On Intellectual Property Protection For ARC-520 6/16/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Expanding Stem Cell Technology Platform 6/16/2014
Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents 6/12/2014
Alnylam Pharmaceuticals (ALNY) Announces United States Patent And Trademark Office (USPTO) Issues Patent Covering Rnai Therapeutics For The Treatment Of Hepatitis B Virus (HBV) Infection 6/12/2014
Zealand Pharma  (ZEAL.CO)’s GLP-2 Analogue European Patent Rights Upheld By The European Patent Office Opposition Division 6/12/2014
Spherix (SPEX) Commences Litigation Against Verizon For Patent Infringement 6/12/2014
The United States Patent Office Grants Neol Biosolutions The Patent For The Technology Microbioil-1® 6/12/2014
Catabasis Pharmaceuticals, Inc. Announces Issuance Of Three New US Patents For CAT-1000 Series 6/11/2014
BioLineRx Ltd. Receives Notice Of Allowance For US Patent Covering Novel Treatment For Celiac Disease 6/11/2014
Stemedica Cell Technologies, Inc. Earns U.S. Patent For Cellular Scaffold Enhanced By Stem Cell Factors 6/10/2014
Palatin Technologies (PTN) Announces Notification Of Patent Allowance On Next Generation Melanocortin Receptor-Specific Peptides 6/10/2014
Titan Pharmaceuticals (TTP) Receives Notice Of Allowance For Patent Of Implantable Polymeric Device For Sustained Release Of Dopamine Agonists 6/10/2014
iBio, Inc. (IBIO) Expands IP Protection Of Biotherapeutic Product For Treatment Of Fibrosis 6/10/2014
Xenetic Biosciences Strengthens Technology Patent Portfolio 6/9/2014
Galmed Pharmaceuticals Announces The Filing Of A Provisional Patent Application For The Use Of Aramchol For The Treatment Of Lipodystrophy 6/9/2014
PharmAthene, Inc. (PIP) Granted U.S. Patent For Recombinant Bioscavenger 6/9/2014
Enzo Biochem (ENZ) Awarded U.S. Patent On More Efficient Vector For Use In Gene Therapy 6/6/2014
Marina Biotech, Inc. (MRNA) Receives Decision To Grant Japanese Patent For Its SMARTICLES Nucleic Acid Delivery Technology 6/6/2014
AMAG Pharmaceuticals, Inc. (AMAG) Announces Patent Term Extension For Ferumoxytol In The U.S. 6/6/2014
Qu Biologics Granted Broad New Zealand Patent Involving Immunotherapies Derived From Viruses For Treating A Range Of Cancers 6/5/2014
Scancell: DNA ImmunoBody Patent Granted In United States 6/5/2014
iBio, Inc. (IBIO) European Patent On iBioModulator Technology Emerges From Opposition Period 6/5/2014
Anavex Life Sciences Corp. (AVXL.OB) Awarded New U.S. Patent 6/4/2014
Suven Life Sciences Ltd Secures One Product Patent In U.S.A. 6/4/2014
Actavis (ACT) Announces Nuvigil® Patent Challenge Settlement 6/2/2014
Mylan Inc. (MYL) Settles Patent Litigation Related To Celebrex® Capsules 6/2/2014
ERYtech Pharma Strengthens Its Intellectual Property Portfolio 6/2/2014
Actavis (ACT) Confirms Generic Onglyza® Patent Challenge 5/28/2014
Galectin Therapeutics Receives U.S. Patent For GR-MD-02 In Diabetic Nephropathy, A Progressive Kidney Disease 5/28/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding 5/28/2014
Iroko Pharmaceuticals Granted Key Patent For TIVORBEX™ 5/28/2014
Batu Biologics Files Patent Covering Its Proprietary Cancer Vaccine Targeting The Tumor Endothelium: Vallovax 5/27/2014
Hemispherx Biopharma (HEB) Receives New U.S. Composition Of Matter Patent Covering Ampligen® Formulations 5/27/2014
Prima Biomed (PRR.AX)'s CVac Patent Application Receives U.S. Notice Of Allowance 5/27/2014
Transposagen Biopharmaceuticals, Inc. Issued Key U.S. Patent Covering Rat Models Of Cancer 5/23/2014
Innovus Pharma Announces The Issuance Of A New Canadian Patent For Its Zestra® Product 5/19/2014
Suven Life Sciences Ltd Product Patents In Australia, South Korea And China 5/19/2014
Neos Therapeutics Announces Issuance Of New Patent Covering Composition Of Matter For Company’s Novel ADHD Products 5/15/2014
BioLight Announces U.S. Patent Approval For Its Formulation Of Latanoprost In Its Proprietary Controlled Release Insert For The Treatment Of Glaucoma 5/14/2014
Appethyl's U.S. Patent, "Use Of Plant Cell Membrane For The Treatment Of Obesity" Issued To Greenleaf Medical AB 5/13/2014
Batu Biologics Files Patent Covering New Use Of Approved Drug For Decreasing Cancer Immunotherapy Toxicity 5/12/2014
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In Canada 5/12/2014
Omni Bio Pharmaceutical Announces Grant Of New Use Patent In Europe 5/8/2014
Pivotal Therapeutics Inc. Announces Issuance Of U.S. Patent 8,715,648 For Its Unique 6:1 EPA:DHA Formulation 5/8/2014
Can-Fite BioPharma (CFBI) Receives Patent In European Union For Treatment Of Liver Function Following Surgery 5/8/2014
Synthetic Biologics, Inc. (SYN) Announces Recent International Patents That Bolster Its C. Difficile Program 5/8/2014
AtheroNova Inc. (AHRO.OB) Receives Notice Of Issuance Of Its 2nd US Patent 8,697,633 5/8/2014
Discovery Laboratories (DSCO) Expands Exclusivity Portfolio With Three New U.S. Patents 5/7/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Release: New Japanese Patents Issued Covering Sapacitabine Pharmaceutical Formulations And Combination Treatments 5/5/2014
ADial Pharmaceuticals Announces Issuance Of First U.S. Patent 5/1/2014
Alcobra (ADHD) Issued New US Patent Covering Metadoxine Use For Cognitive Disorders 5/1/2014
Curis, Inc. (CRIS) Announces U.S. Patent Issuance Covering CUDC-907 Composition-Of-Matter 4/30/2014
BioAtla Receives Broad Patent Covering Conditionally Active Biologics 4/30/2014
KemPharm, Inc. Receives Notice Of Allowance For Novel Prodrug Of Hydromorphone 4/30/2014
AVANIR Pharmaceuticals (AVNR) Prevails In NUEDEXTA Patent Trial Resulting In Exclusivity Through 2026 4/30/2014
Braasch Biotech Continues To Build Patent Portfolio With Acceptances In The European Union, Russia And Israel 4/28/2014
Epizyme (EPZM) Announces Notice Of Allowance For U.S. Patent Application Covering Methods Of Treatment For Cancers With EZH2 Inhibitors 4/24/2014
U.S. District Court Finds In Favor Of Azbil BioVigilant, Inc. In Patent Litigation Dispute 4/24/2014
Actavis (ACT) Announces Celebrex® Patent Challenge Settlement 4/24/2014
iBio, Inc. (IBIO) Receives Patent Allowance In China For Fusion Protein Compositions And Technology 4/24/2014
Premier Biomedical Receives Notice Of Allowance On Broad Base Patent 4/24/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For U.S. Patent Expanding Stem Cell Technology Platform For Drug Rescue And Regenerative Medicine 4/23/2014



//-->